How I Approach Ethical Considerations for Pediatric Phase I CAR T-Cell Trials
{{output}}
Phase I trials of chimeric antigen receptor (CAR) T cells have shown remarkable promise in pediatric B-cell malignancies. Such outcomes have shifted expectations for other phase I CAR T-cell trials to have high response rates. The juxtaposition of high expecta... ...
